A next-generation gene therapy company pioneering the development of targeted non-viral gene therapies for rare and prevalent genetic diseases.
- Year invested 2021
- Investment Stage Seed
- Board Members
- Sectors
- Investment Status Current
- Associated Team
- Website codebiotx.com
- Company Status Private